Navigation Links
Cancer experience worse for young adults in spite of better survival odds
Date:11/9/2010

ANN ARBOR, Mich. Younger adult cancer patients have the most difficulty coping with the pain and emotional issues of cancer, in spite of their potentially better survival odds, according to a University of Michigan Health System study.

The study, which included mostly breast and lung cancer patients, appears in the November issue of Pain Medicine, a journal of the American Academy of Pain Medicine.

Adult cancer patients age 40 and under had more pain flares and more difficulty thinking quickly and logically six months after their diagnosis compared to older adults.

Pain also affected their mood more often than adults in their 50s or 60s.

Cancer pain is common, whether it is consistent discomfort or patient flares that interrupt well-controlled pain. International studies suggest nearly 70 percent of people dying from cancer experience unrelieved pain.

"Our study provides evidence for the significant toll of cancer pain on overall health and well-being of young and old adults alike, but demonstrate an increased toll for younger adults, especially financially," says study lead author Carmen R. Green, M.D., a U-M professor of anesthesiology, obstetrics and gynecology, and health management and policy.

In the study, researchers revealed a trend of younger groups having pain in more locations 4.5 locations compared to 2.2 for older adults up to six months after diagnosis.

Older adults reported mostly spinal pain, and younger adults reported pain in the spine, back, arms, abdomen and elsewhere, according to the study.

Young adult cancer patients reported smaller incomes and, perhaps as a result had more difficulty paying health care bills.

In the survey, 75 percent of young patients reported having trouble paying for health care which was twice the rate reported by older adults.

Green, along with co-author Tamera Hart-Johnson, M.S., a senior research associate at U-M, surveyed about 100 patients with advanced stages of breast, lung, colorectal and prostate cancer, and multiple myeloma, a bone marrow cancer.

Among three age groups, the youngest set of those age 40 and younger had the greatest pain interference, but reported improvement over time, according to the study.

For example, 8 percent of young adults said pain affected their mood compared to 4.35 percent of adults in the 41-59 age group, and 4.14 percent among those age 60 and older.

"The groups did not look different mentally or emotionally at the time of diagnosis, although both cognitive functioning and depression worsened for young adults by six months as their treatments and battle with cancer continued," Green says.

The oldest group had better emotional functioning at the start, but by six months had significantly worse physical functioning.

Future studies should attempt to determine how patient age influences patient preferences and attitudes about cancer pain management.

As more people survive cancer, the authors urge that future studies attempt to determine how patient age influences patient preferences and attitudes about cancer pain management.

Additional studies might examine potential differences in support systems, coping strategies, and other factors that may impact overall health, such as caregiving, health insurance and employment, Green says.


'/>"/>

Contact: Shantell M. Kirkendoll
smkirk@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Related medicine news :

1. Combined imaging technologies may better identify cancerous breast lesions
2. New research shows genetic test for lung cancer risk prompts smokers to quit
3. Obesity Not Tied to Breast Cancer Risk in Mexican Americans
4. Smoking May Raise Risk of Death in Women With Breast Cancer
5. Statins Dont Reduce Colon Cancer Risk, Study Finds
6. Massachusetts Institute of Technology IDs new cancer drug target
7. Breast cancer: Reducing the risk of unnecessary chemo
8. Statins did not reduce colorectal cancer in WHI analysis
9. PIT(-1)ting good and bad outcomes against each other in breast cancer
10. Hebrew University researchers discover expanded role for cancer-causing gene
11. Joint pain linked to breast cancer drug not inflammatory arthritis or autoimmune disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer experience worse for young adults in spite of better survival odds
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: